PINK:BIOVF

Swedish Orphan Biovitrum AB (publ) Stock Insider Trading

Pink Sheets > Healthcare > Drug Manufacturers—Specialty & Generic

$25.76

+0 (+0%)

At Close: Jun 25, 2024

Swedish Orphan Biovitrum AB (publ) Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 BIOVF shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin ... BIOVF Profile

Golden Star

Ticker	Date	Change	Price
EVBG	Jun 21	0.0863%	$34.76
DDOG	Jun 21	1.33%	$117.57
BRK-A	Jun 20	0.575%	$617,249.90
EPD	Jun 18	2.90%	$28.30
USFD	Jun 18	4.33%	$53.14
INTC	Jun 18	0.359%	$30.63
UFPT	Jun 18	2.05%	$253.79
^DJI	Jun 18	0.714%	38,834.86 points
RGA	Jun 17	1.53%	$203.90
MA	Jun 17	1.68%	$448.11

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In